Gallic acid inhibits gastric cancer cells metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity.

Our previous study demonstrated the therapeutic potential of gallic acid (GA) for controlling tumor metastasis through its inhibitory effect on the motility of AGS cells. A noteworthy finding in our previous experiment was increased RhoB expression in GA-treated cells. The aim of this study was to evaluate the role of RhoB expression on the inhibitory effects of GA on AGS cells. By applying the transfection of RhoB siRNA into AGS cells and an animal model, we tested the effect of GA on inhibition of tumor growth and RhoB expression. The results confirmed that RhoB-siRNA transfection induced GA to inhibit AGS cells' invasive growth involving blocking the AKT/small GTPase signals pathway and inhibition of NF-κB activity. Finally, we evaluated the effect of GA on AGS cell metastasis by colonization of tumor cells in nude mice. It showed GA inhibited tumor cells growth via the expression of RhoB. These data support the inhibitory effect of GA which was shown to inhibit gastric cancer cell metastasis and invasive growth via increased expression of RhoB, downregulation of AKT/small GTPase signals and inhibition of NF-κB activity. Thus, GA might be a potential agent in treating gastric cancer.

[1]  Yi Zheng,et al.  A distinct role of RhoB in gastric cancer suppression , 2011, International journal of cancer.

[2]  Kyoko Arai,et al.  Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  J. Lambert,et al.  The role of RhoC in growth and metastatic capacity of melanoma , 2009, Journal of cutaneous pathology.

[4]  T. Kamai,et al.  Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour , 2001, BJU international.

[5]  G. Prendergast,et al.  RhoB Is Dispensable for Mouse Development, but It Modifies Susceptibility to Tumor Formation as Well as Cell Adhesion and Growth Factor Signaling in Transformed Cells , 2001, Molecular and Cellular Biology.

[6]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[7]  M. Poupon,et al.  Inhibition of constitutive NF-kappa B activity suppresses tumorigenicity of Ewing sarcoma EW7 cells. , 2002, International journal of cancer.

[8]  M. Sasako,et al.  Lymph node metastases of gastric cancer. General pattern in 1931 patients. , 1989, Annals of surgery.

[9]  G. Prendergast,et al.  RhoB in cancer suppression. , 2006, Histology and histopathology.

[10]  M. Kuo,et al.  Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone-induced apoptosis through an oxidation-dependent pathway. , 1999, Cancer research.

[11]  Huei-Mei Chen,et al.  Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells. , 2009, Cancer letters.

[12]  T. Nikaido,et al.  Up-Regulation of Small GTPases, RhoA and RhoC, Is Associated with Tumor Progression in Ovarian Carcinoma , 2003, Laboratory Investigation.

[13]  Tae-Wook Chung,et al.  Hepatitis B viral HBx induces matrix metalloproteinase‐9 gene expression through activation of ERKs and PI‐3K/AKT pathways: Involvement of invasive potential , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  W. Park,et al.  Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  B. Kaina,et al.  Rho GTPases are over‐expressed in human tumors , 1999, International journal of cancer.

[16]  B. Kaina,et al.  Rho GTPases: promising cellular targets for novel anticancer drugs. , 2006, Current cancer drug targets.

[17]  Chi-Sen Chang,et al.  Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-kappaB activity and downregulation of PI3K/AKT/small GTPase signals. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[18]  S. Sebti,et al.  Suppression of rho B expression in invasive carcinoma from head and neck cancer patients. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  D. Dent,et al.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma , 1988, The British journal of surgery.

[20]  S. Fushida,et al.  Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph node. , 1991, International surgery.

[21]  T. Tseng,et al.  Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways. , 2006, Chemico-biological interactions.

[22]  J. Mazières,et al.  Loss of RhoB Expression in Human Lung Cancer Progression , 2004, Clinical Cancer Research.

[23]  A. Chung,et al.  Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation. , 2006, Carcinogenesis.

[24]  D. Spandidos,et al.  Uterine cervical carcinoma: role of matrix metalloproteinases (review). , 2009, International journal of oncology.

[25]  M. Poupon,et al.  Inhibition of constitutive NF‐κB activity suppresses tumorigenicity of ewing sarcoma EW7 cells , 2002 .

[26]  D. Kelsen.  The use of chemotherapy in the treatment of advanced gastric and pancreas cancer. , 1994, Seminars in oncology.

[27]  Yiling Lu,et al.  Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery , 2005, Nature Reviews Drug Discovery.

[28]  M. Shipitsin,et al.  Activation of RalA is critical for Ras-induced tumorigenesis of human cells. , 2005, Cancer cell.

[29]  C. Der,et al.  Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation , 1995, Molecular and cellular biology.

[30]  K. Jiang,et al.  Akt Mediates Ras Downregulation of RhoB, a Suppressor of Transformation, Invasion, and Metastasis , 2004, Molecular and Cellular Biology.

[31]  S. Sebti,et al.  Both Farnesylated and Geranylgeranylated RhoB Inhibit Malignant Transformation and Suppress Human Tumor Growth in Nude Mice* , 2000, The Journal of Biological Chemistry.